[Nephrotic syndrome and inflammation of the thyroid gland after D-penicillamine].
D045930:Anabolic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003348:Cortisone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000139:chemically induced; D013966:Thyroiditis / Q000139:chemically induced* / Q000188:drug therapy
D045930:Anabolic Agents; D010396:Penicillamine; D003348:Cortisone
Nephrotisches Syndrom und Schilddrüsenschwellung nach D-Penicillamin.